CenterPoint Energy: Houston's data-center load growth is underwritten, but the balance sheet is doing the heavy lifting

Stevie AI on CenterPoint Energy, Inc. (CNP-USA | centerpointe)

9/20/2026

Summary

CenterPoint Energy is a regulated electric and gas utility anchored by Houston Electric, where large-load demand from data centers and reshored manufacturing is driving guided rate base growth of over 18% annually through 2029. The structural insight is straightforward: Texas's ERCOT market is attracting massive incremental electricity demand, and CenterPoint's transmission and distribution franchise sits directly in the path of that growth, with a $66.7B multi-year capital plan and visibility to $10B+ more. The company has also quantified the economics well, citing roughly $6 million per gigawatt per month in incremental demand-charge cash flow as Batch Zero projects energize in 2027-2029, which gives investors a tangible bridge from capex to earnings. Recent financial performance shows steady but unspectacular progress: revenue grew from $8.6B in FY2024 to $9.4B in FY2025, while EPS inched up from $1.58 to $1.60, reflecting share count dilution and rising interest expense offsetting underlying operating growth. Management has reiterated 2026 non-GAAP EPS guidance of $1.89-$1.91 (roughly 8% growth), and longer-term guidance calls for 7-9% annual EPS growth through 2028 and beyond, consistent with our forecast path of $1.73 in 2026 rising to $1.98 by 2029 on a GAAP basis. The gap between non-GAAP guidance and our GAAP-based EPS forecast reflects the growing drag from financing costs as net debt climbs from roughly $27.8B in 2026 to $41.7B by 2029 to fund negative free cash flow averaging roughly $2.7B annually. We apply a 19x forward P/E multiple, consistent with premium-growth regulated utilities exhibiting above-average rate base CAGRs, yielding price targets of $32.87 (2026), $35.34 (2027), $36.29 (2028), and $37.62 (2029). At the current price of $38.22, the stock already trades above our 2029 target on a GAAP EPS basis, implying the market has priced in successful execution of the entire Batch Zero pipeline and additional capital visibility without much room for delay or dilution risk. We rate the stock HOLD: the growth story is real and well-underwritten by regulatory mechanisms, but the current valuation leaves little margin of safety against the financing and execution risks embedded in a capex plan that nearly doubles net debt in four years.

Thesis

1. **Regulated Growth With Real Underwriting** — CenterPoint's investment case rests on Houston Electric's rate base growing at a guided 18%+ CAGR through 2029, driven by large-load capital deployment tied to data centers and industrial reshoring. Unlike merchant power exposure, this growth flows through cost-of-service regulation, meaning capital deployed on approved projects earns a contractual return rather than depending on volatile market prices. Management's disclosure that new large-load demand charges generate approximately $6 million per gigawatt per month provides a granular, verifiable link between capex and cash flow, and with 3 GW of Batch Zero projects slated for energization in 2027 and 10 GW of baseload projects already under construction, the near-term earnings bridge is more visible than for most regulated utilities pursuing growth narratives. 2. **Capital Intensity Is the Business Model, Not a Side Effect** — The $66.7B multi-year capital plan, with $6.8B earmarked for 2026 alone and visibility to $10B+ of incremental investment through 2035, is the mechanism by which CenterPoint converts Houston's electricity demand growth into rate base and earnings growth. This is a capital-intensive but low-risk model in principle: regulators pre-approve investment programs and utilities earn allowed returns on deployed capital. The forecast trajectory of net debt rising from $27.8B in 2026 to $41.7B in 2029, alongside consistently negative free cash flow of $2.5-2.8B annually, reflects the funding requirement rather than distress, but it does mean equity holders are increasingly exposed to interest rate and refinancing risk as leverage builds. 3. **Margin Structure Is Stable but Compressing at the Net Income Line** — Commodity pass-through costs for gas and petroleum, tracked against a WTI band of $80-100/bbl near-term normalizing to $80 by 2028-2029, have minimal net margin impact given the pass-through mechanics — CenterPoint is not taking commodity price risk on this line. However, rising interest expense from debt-funded capex is growing faster than revenue, which explains why net income grows more slowly than revenue across the forecast (from $1.1B in 2026 to $1.4B in 2029 against revenue growing from $10.0B to $12.0B). This is a classic capital-intensive utility dynamic: topline and rate base growth do not translate one-for-one into EPS growth once financing costs are accounted for. 4. **EPS Growth Guidance Assumes Disciplined Equity Issuance** — Management's framework of calibrating modest ATM issuance against op-ex and dividend-funded buybacks in later years is designed to keep share count growth aligned with the 7-9% EPS growth target rather than diluting it away, as has occurred with some utility growth stories. Our EPS forecast of $1.73 (2026) rising to $1.98 (2029) is consistent with this framework, though it sits below management's non-GAAP guidance of $1.89-$1.91 for 2026, reflecting the more conservative GAAP treatment applied in our model. The delta between guidance and our estimate is a key variable investors should track each quarter for signs of over- or under-delivery. 5. **The Market May Be Ahead of the Execution Curve** — At $38.22, the stock trades above every one of our annual price targets derived from a 19x forward multiple on GAAP EPS, including the 2029 target of $37.62. This suggests the market is either applying a materially higher multiple than growth-adjusted utility peers typically command, or pricing in EPS materially above our GAAP forecast — plausible if the non-GAAP guidance path proves durable and if none of the Batch Zero pipeline slips. The Q4 2026 transmission study catalyst could re-rate the stock further if it validates the $10B+ additional capital opportunity, but until that scope is confirmed, current pricing leaves little cushion for delay. 6. **Competitive Position Is Durable But Not Exceptional** — CenterPoint's franchise position in Houston, an ERCOT-interconnected market with genuine structural demand tailwinds, is a real advantage versus utilities in slower-growth service territories. But it competes for large-load customer connections against Oncor (AEP), NextEra's Florida franchises, and municipal utilities, meaning some of the demand growth currently modeled could migrate to competing transmission providers if CenterPoint's own system hardening and import capacity lag behind. The Blue Ocean scoring of 6.0-7.0 reflects this: CenterPoint is capturing new demand categories within an existing regulated framework, not redefining the category, which caps the multiple premium justified relative to true structural moats.

Risks

1. **Batch Zero Materialization and Timing Risk** — The 14 GW large-load pipeline depends on customers securing their own regulatory approvals, permits, and maintaining investment commitments over multi-year horizons. ERCOT's load-allocation decision scheduled for April 2027 is a specific, dated risk event that could compress or extend the energization timeline for projects not yet baseload or study-load eligible, directly affecting the demand-charge cash flow ramp management has guided to in 2027-2029. 2. **Leverage Escalation and Refinancing Risk** — Net debt is forecast to grow from roughly $27.8B in 2026 to $41.7B in 2029, an increase of nearly 50% in four years, funding persistently negative free cash flow. If interest rates rise further or credit spreads widen for utility issuers, financing costs could compress net income growth more than modeled, and a ratings downgrade would raise the cost of capital across the entire $66.7B capital program. 3. **Regulatory Lag and Rate Case Risk** — While cost-of-service regulation provides revenue visibility, actual recovery depends on constructive outcomes in Texas and other state rate cases. Delays in rate case approvals, disallowed capital, or unfavorable allowed ROE determinations could slow the translation of capex into earned returns, particularly as the capital program scales toward $10B+ of additional investment. 4. **Valuation Already Prices In Near-Perfect Execution** — At $38.22, the stock trades above our price targets across the entire 2026-2029 forecast horizon using a 19x multiple on GAAP EPS. This leaves the stock vulnerable to multiple compression if growth decelerates, if the transmission study reveals higher-than-expected incremental capex needs without commensurate rate base benefit, or if broader utility sector multiples de-rate in a higher-for-longer rate environment. 5. **Share Count and Dilution Risk** — Management's plan to calibrate equity issuance against buybacks assumes favorable capital markets access throughout the forecast period. If equity markets are less receptive or the company needs to issue more ATM equity than planned to fund the capital program without further leverage, EPS growth could fall short of the 7-9% guided range despite healthy net income growth. 6. **Commodity and Weather Pass-Through Timing Mismatches** — Although commodity costs are structured as pass-throughs with minimal net margin impact, working capital timing mismatches between when gas/petroleum costs are incurred and when they are recovered from customers can create short-term cash flow volatility, compounding the already negative free cash flow profile during a period of heavy capital deployment.

📈 Price Targets